FAM167B
gene geneOn this page
Also known as MGC10820DIORA-2
Summary
FAM167B (family with sequence similarity 167 member B, HGNC:28133) is a protein-coding gene on chromosome 1p35.2, encoding Protein FAM167B (Q9BTA0).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_032648
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28133 |
| Approved symbol | FAM167B |
| Name | family with sequence similarity 167 member B |
| Location | 1p35.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC10820, DIORA-2 |
| Ensembl gene | ENSG00000183615 |
| Ensembl biotype | protein_coding |
| Entrez | 84734 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000373582, ENST00000857788
RefSeq mRNA: 1 — MANE Select: NM_032648
NM_032648
CCDS: CCDS358
Canonical transcript exons
ENST00000373582 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001650391 | 32247222 | 32247682 |
| ENSE00001743279 | 32248371 | 32248856 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 89.81.
FANTOM5 (CAGE): breadth broad, TPM avg 2.0095 / max 131.8246, expressed in 533 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1966 | 1.7233 | 505 |
| 1967 | 0.1248 | 52 |
| 1969 | 0.0841 | 27 |
| 1968 | 0.0774 | 25 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 89.81 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.56 | gold quality |
| apex of heart | UBERON:0002098 | 87.70 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.23 | gold quality |
| metanephros cortex | UBERON:0010533 | 85.92 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 85.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.11 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 84.45 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.35 | gold quality |
| left adrenal gland | UBERON:0001234 | 83.98 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 83.94 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.87 | gold quality |
| adrenal cortex | UBERON:0001235 | 83.81 | gold quality |
| pituitary gland | UBERON:0000007 | 83.69 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 83.65 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 82.96 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 82.50 | gold quality |
| upper arm skin | UBERON:0004263 | 82.46 | gold quality |
| thyroid gland | UBERON:0002046 | 82.14 | gold quality |
| upper lobe of lung | UBERON:0008948 | 82.07 | gold quality |
| omental fat pad | UBERON:0010414 | 82.04 | gold quality |
| peritoneum | UBERON:0002358 | 82.01 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 81.96 | gold quality |
| endocervix | UBERON:0000458 | 81.46 | gold quality |
| body of uterus | UBERON:0009853 | 81.42 | gold quality |
| myometrium | UBERON:0001296 | 81.10 | gold quality |
| adrenal gland | UBERON:0002369 | 81.08 | gold quality |
| metanephros | UBERON:0000081 | 81.03 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 80.65 | gold quality |
| pericardium | UBERON:0002407 | 79.44 | silver quality |
Single-cell (SCXA)
Detected in 9 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-1 | yes | 46.01 |
| E-MTAB-10553 | yes | 45.80 |
| E-HCAD-11 | yes | 45.45 |
| E-HCAD-10 | yes | 36.38 |
| E-MTAB-6701 | yes | 29.29 |
| E-MTAB-8410 | yes | 20.59 |
| E-HCAD-9 | yes | 11.81 |
| E-ANND-3 | yes | 5.44 |
| E-MTAB-6678 | no | 2.43 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting FAM167B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-877-3P | 99.09 | 68.10 | 1637 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
| HSA-MIR-6804-5P | 98.39 | 65.77 | 1084 |
| HSA-MIR-7703 | 97.64 | 67.00 | 965 |
| HSA-MIR-4689 | 96.97 | 65.79 | 1209 |
| HSA-MIR-1292-5P | 96.74 | 62.14 | 238 |
| HSA-MIR-6858-5P | 96.05 | 64.59 | 1020 |
| HSA-MIR-4471 | 95.11 | 66.84 | 755 |
| HSA-MIR-8059 | 95.11 | 66.30 | 646 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam167b | ENSDARG00000100426 |
| mus_musculus | Fam167b | ENSMUSG00000050493 |
| rattus_norvegicus | Fam167b | ENSRNOG00000049425 |
Paralogs (3): FAM167A (ENSG00000154319), AARD (ENSG00000205002), C20orf202 (ENSG00000215595)
Protein
Protein identifiers
Protein FAM167B — Q9BTA0 (reviewed: Q9BTA0)
All UniProt accessions (1): Q9BTA0
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM167 (SEC) family.
RefSeq proteins (1): NP_116037* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024280 | FAM167 | Family |
| IPR051771 | FAM167_domain | Family |
Pfam: PF11652
UniProt features (2 total): chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BTA0-F1 | 76.85 | 0.29 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, chr1p35, HORIUCHI_WTAP_TARGETS_UP, NFE2L2.V2, SUPT16H_TARGET_GENES, TFEB_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP, MIR5193, GSE11924_TH2_VS_TH17_CD4_TCELL_UP, MIR7703, MIR4689, MIR6858_5P, GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP, GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP, GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
184 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM167B | FAM124A | Q86V42 | 566 |
| FAM167B | FHIP2A | Q5W0V3 | 560 |
| FAM167B | CYTL1 | Q9NRR1 | 518 |
| FAM167B | FCRL6 | Q6DN72 | 481 |
| FAM167B | FAM124B | Q9H5Z6 | 437 |
| FAM167B | STK33 | Q9BYT3 | 430 |
| FAM167B | EHD3 | Q9NZN3 | 411 |
| FAM167B | SLC35H1 | Q9NQQ7 | 374 |
| FAM167B | WDR86 | Q86TI4 | 370 |
| FAM167B | DTD2 | Q96FN9 | 352 |
| FAM167B | FHIP2B | Q86V87 | 336 |
| FAM167B | ZFYVE19 | Q96K21 | 324 |
| FAM167B | PNMA8A | Q86V59 | 323 |
| FAM167B | FAM184A | Q8NB25 | 323 |
| FAM167B | LRRC14 | Q15048 | 307 |
IntAct
113 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM167B | LNX2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | MAGI1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAGI2 | FAM167B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | TJP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| LNX1 | FAM167B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | RADIL | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | HTRA4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | HTRA3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | HTRA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | HTRA2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | DLG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | TAMALIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | DLG1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | NHERF4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | MAGI2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | GRID2IP | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | ARHGEF12 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | PDZK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FRMPD2 | FAM167B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | LIN7B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FAM167B | WHRN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
ESM2 similar proteins: A1L168, A1L3T7, A6NGS2, A6QQF7, D4A8G3, O15049, P0C7N2, P0C7N4, P17257, P58660, Q08AY9, Q0V7M8, Q0VDN7, Q14BJ1, Q2NL23, Q3KP66, Q3LUD3, Q3UNU4, Q4LEZ3, Q566R4, Q571B6, Q5BJW5, Q5ND29, Q5RFZ7, Q5XIS1, Q6NSJ2, Q6P1G6, Q6Q0N2, Q7TN12, Q7TSI1, Q811W1, Q8BL43, Q8C7U1, Q8IV03, Q8K1S6, Q8K2P1, Q8N137, Q8N5H3, Q8TE77, Q8WWL2
Diamond homologs: P17257, Q0V7M8, Q5RFZ7, Q6P1G6, Q96KS9, Q9BTA0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 73 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 59.5× | 7e-07 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 56.6× | 7e-07 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 56.6× | 7e-07 |
| Assembly and cell surface presentation of NMDA receptors | 10 | 52.9× | 2e-13 |
| Dopamine Neurotransmitter Release Cycle | 5 | 51.7× | 1e-06 |
| Long-term potentiation | 5 | 49.6× | 1e-06 |
| Neurexins and neuroligins | 11 | 45.1× | 8e-14 |
| Protein-protein interactions at synapses | 7 | 38.7× | 3e-08 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 91.3× | 4e-17 |
| protein localization to synapse | 6 | 65.7× | 3e-08 |
| receptor clustering | 7 | 62.4× | 3e-09 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 49.6× | 1e-08 |
| protein-containing complex assembly | 9 | 14.6× | 6e-07 |
| cell-cell adhesion | 10 | 14.5× | 1e-07 |
| protein localization to plasma membrane | 5 | 7.8× | 7e-03 |
| chemical synaptic transmission | 7 | 7.7× | 8e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
170 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:32247679:GCTG:G | donor_gain | 0.9900 |
| 1:32247681:TGGTG:T | donor_loss | 0.9900 |
| 1:32247683:GTG:G | donor_loss | 0.9900 |
| 1:32247684:T:G | donor_loss | 0.9900 |
| 1:32248369:A:AG | acceptor_gain | 0.9900 |
| 1:32248369:AGCG:A | acceptor_gain | 0.9900 |
| 1:32248370:G:GG | acceptor_gain | 0.9900 |
| 1:32248370:GCGG:G | acceptor_gain | 0.9900 |
| 1:32247683:G:GG | donor_gain | 0.9800 |
| 1:32248369:AGC:A | acceptor_gain | 0.9800 |
| 1:32248370:GC:G | acceptor_gain | 0.9800 |
| 1:32248370:GCG:G | acceptor_gain | 0.9800 |
| 1:32247685:GA:G | donor_loss | 0.9700 |
| 1:32248369:AGCGG:A | acceptor_gain | 0.9600 |
| 1:32248370:GCGGG:G | acceptor_gain | 0.9600 |
| 1:32248372:G:A | acceptor_gain | 0.9600 |
| 1:32248366:C:A | acceptor_gain | 0.9500 |
| 1:32248366:CGCA:C | acceptor_loss | 0.9400 |
| 1:32248367:GCA:G | acceptor_loss | 0.9400 |
| 1:32248368:CA:C | acceptor_loss | 0.9400 |
| 1:32248369:AG:A | acceptor_loss | 0.9400 |
| 1:32248370:G:A | acceptor_loss | 0.9400 |
| 1:32248371:CGGG:C | acceptor_gain | 0.9400 |
| 1:32247570:TCCA:T | donor_gain | 0.9100 |
| 1:32248371:C:CA | acceptor_gain | 0.9100 |
| 1:32247680:CTG:C | donor_gain | 0.9000 |
| 1:32247681:TG:T | donor_gain | 0.9000 |
| 1:32247682:GG:G | donor_gain | 0.9000 |
| 1:32248364:GCCGC:G | acceptor_loss | 0.9000 |
| 1:32248362:C:A | acceptor_gain | 0.8800 |
AlphaMissense
1026 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:32248587:T:C | F160L | 0.976 |
| 1:32248589:C:A | F160L | 0.976 |
| 1:32248589:C:G | F160L | 0.976 |
| 1:32247638:T:C | F73L | 0.956 |
| 1:32247640:C:A | F73L | 0.956 |
| 1:32247640:C:G | F73L | 0.956 |
| 1:32247559:G:C | W46C | 0.943 |
| 1:32247559:G:T | W46C | 0.943 |
| 1:32248571:C:A | N154K | 0.942 |
| 1:32248571:C:G | N154K | 0.942 |
| 1:32248588:T:C | F160S | 0.940 |
| 1:32247557:T:A | W46R | 0.925 |
| 1:32247557:T:C | W46R | 0.925 |
| 1:32247505:G:C | K28N | 0.920 |
| 1:32247505:G:T | K28N | 0.920 |
| 1:32248573:T:C | I155T | 0.906 |
| 1:32248568:G:A | M153I | 0.899 |
| 1:32248568:G:C | M153I | 0.899 |
| 1:32248568:G:T | M153I | 0.899 |
| 1:32248570:A:T | N154I | 0.897 |
| 1:32248445:G:C | K112N | 0.887 |
| 1:32248445:G:T | K112N | 0.887 |
| 1:32248573:T:A | I155N | 0.878 |
| 1:32248567:T:C | M153T | 0.874 |
| 1:32248569:A:G | N154D | 0.874 |
| 1:32248588:T:G | F160C | 0.874 |
| 1:32247681:T:C | L87P | 0.873 |
| 1:32248573:T:G | I155S | 0.872 |
| 1:32247669:T:C | L83P | 0.870 |
| 1:32248411:T:C | L101P | 0.854 |
dbSNP variants (sampled 300 via entrez): RS1000352411 (1:32245943 TTTATTTAC>T,TTTATTTACTTATTTAC), RS1000383488 (1:32246330 C>T), RS1001098526 (1:32246701 A>G), RS1001352826 (1:32247270 C>T), RS1001462083 (1:32248305 A>G), RS1001530140 (1:32247032 C>G), RS1001831129 (1:32248035 G>T), RS1003686192 (1:32248660 C>A), RS1003718715 (1:32248885 G>C), RS1003861704 (1:32245668 A>C), RS1004904125 (1:32245264 G>T), RS1005943286 (1:32249152 C>A,T), RS1006019147 (1:32247710 C>A), RS1006622281 (1:32246927 G>A,T), RS1007167340 (1:32248284 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009597_83 | Multiple sclerosis | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| sulforaphane | decreases expression | 1 |
| sodium arsenite | affects methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.